Julie Frisolone serves as the Associate Director of Publications at Regeneron Pharmaceuticals, Inc., where she plays a pivotal role in advancing the company’s health economic and outcomes research (HEOR) initiatives. With a robust background in medical affairs, Julie is adept at managing publication strategies that...
Julie Frisolone serves as the Associate Director of Publications at Regeneron Pharmaceuticals, Inc., where she plays a pivotal role in advancing the company’s health economic and outcomes research (HEOR) initiatives. With a robust background in medical affairs, Julie is adept at managing publication strategies that align with lifecycle management plans for key therapeutic areas, including immunology and ophthalmology. Her current focus on dupilumab, REGEN-COV, and ophthalmology underscores her expertise in navigating complex publication landscapes while ensuring compliance with industry guidelines.
In her role, Julie leads a cross-functional publication team, fostering collaboration among clinical development, medical writing, and strategic marketing to define and execute comprehensive publication strategies. She is instrumental in identifying key congresses and journals for disseminating research findings, thereby enhancing the visibility and impact of Regeneron’s innovative therapies. Her experience in the strategic and tactical execution of publications for products such as aflibercept and sarilumab further solidifies her reputation as a results-driven professional committed to advancing medical knowledge and improving patient outcomes.
Julie’s proficiency in publication planning and execution is complemented by her deep understanding of medical affairs activities, including the review and approval of promotional materials and medical information. Her ability to develop and present long-range and short-term goals ensures that Regeneron remains at the forefront of scientific communication, ultimately supporting the company’s mission to deliver transformative medicines to patients. With her extensive skill set in clinical research, neuroscience, and therapeutic areas such as pain management and psychiatry, Julie is a key contributor to Regeneron’s success in the competitive biopharmaceutical landscape.
